Literature DB >> 15287892

Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).

Mella Adlersberg1, Shu-chi Hsiung, Sara B Glickstein, Kuo-peing Liu, Hadassah Tamir, Claudia Schmauss.   

Abstract

Mice lacking dopamine D2 receptors exhibit a significantly decreased agonist-promoted forebrain neocortical D1 receptor activation that occurs without changes in D1 receptor expression levels. This raises the possibility that, in brains of D2 mutants, a substantial portion of D1 receptors are uncoupled from their G protein, a phenomenon known as receptor desensitization. To test this, we examined D1-agonist-stimulated [35S]GTPgammaS binding (in the presence and absence of protein phosphatase inhibitors) and cAMP production (in the presence and absence of pertussis toxin) in forebrain neocortical tissues of wild-type mice and D2-receptor mutants. These studies revealed a decreased agonist-stimulated G-protein activation in D2 mutants. Moreover, whereas protein phosphatase 1/2A (PP1/2A) and 2B (PP2B) inhibitors decrease [35S]GTPgammaS binding in a concentration-dependent manner in wild type, they have either no (PP2B) or only partial (PP1/2A) effects in D2 mutants. Furthermore, for D2 mutants, immunoprecipitation experiments revealed increased basal and D1-agonist-stimulated phosphorylation of D1-receptor proteins at serine residues. Finally, D1 immunoprecipitates of both wild type and D2 mutants also contain protein kinase A (PKA) and PP2B immunoreactivities. In D2 mutants, however, the catalytic activity of the immunoprecipitated PP2B is abolished. These data indicate that neocortical D1 receptors are physically linked to PKA and PP2B and that the increased phosphorylation of D1 receptors in brains of D2 mutants is due to defective dephosphorylation of the receptor rather than increased kinase-mediated phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287892     DOI: 10.1111/j.1471-4159.2004.02562.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Basal and cocaine-induced sex differences in the DARPP-32-mediated signaling pathway.

Authors:  Luyi Zhou; Arbi Nazarian; Wei-Lun Sun; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

2.  Induction of early growth response gene 2 expression in the forebrain of mice performing an attention-set-shifting task.

Authors:  D A DeSteno; C Schmauss
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

Review 3.  Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.

Authors:  Seong-Wook Kim; Taesup Cho; Sukchan Lee
Journal:  Front Psychiatry       Date:  2015-11-17       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.